Literature DB >> 17369845

Cigarette smoke induces demethylation of prometastatic oncogene synuclein-gamma in lung cancer cells by downregulation of DNMT3B.

H Liu1, Y Zhou, S E Boggs, S A Belinsky, J Liu.   

Abstract

The prometastatic oncogene synuclein-gamma (SNCG) is not expressed in normal lung tissues, but it is highly expressed in lung tumors. Here, we show that cigarette smoke extract (CSE) has strong inducing effects on SNCG gene expression in A549 lung cancer cells through demethylation of SNCG CpG island. CSE treatment also augments the invasive capacity of A549 cells in an SNCG-dependent manner. To elucidate the mechanisms underlying the demethylating effects of CSE, we examined expression levels of DNA methyltransferases (DNMTs), 1, 3A and 3B in CSE-treated cells. We show that the mRNA expression of DNMT3B is specifically downregulated by CSE with a kinetics concurrent to SNCG reexpression. Utilizing siRNA to knockdown DNMT3B expression, we show that inhibition of DNMT3B directly increases SNCG mRNA expression. We further show that exogenous overexpression of DNMT3B in an SNCG-positive lung cancer cell line H292 suppresses SNCG mRNA and protein expression and induces de novo methylation of SNCG CpG island, whereas overexpression of DNMT1 or DNMT3A has no effects. Taken together, these new findings demonstrate that tobacco exposure induces the abnormal expression of SNCG in lung cancer cells through downregulation of DNMT3B. This work sheds light on the molecular understanding of demethylation of this oncogene during cancer progression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17369845     DOI: 10.1038/sj.onc.1210400

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  45 in total

1.  Prostaglandin E₂ increases fibroblast gene-specific and global DNA methylation via increased DNA methyltransferase expression.

Authors:  Steven K Huang; Anne M Scruggs; Jake Donaghy; Richard C McEachin; Aaron S Fisher; Bruce C Richardson; Marc Peters-Golden
Journal:  FASEB J       Date:  2012-05-29       Impact factor: 5.191

Review 2.  DNA hypomethylation in the origin and pathogenesis of human diseases.

Authors:  Igor P Pogribny; Frederick A Beland
Journal:  Cell Mol Life Sci       Date:  2009-03-27       Impact factor: 9.261

Review 3.  Prospects for epigenetic epidemiology.

Authors:  Debra L Foley; Jeffrey M Craig; Ruth Morley; Craig A Olsson; Craig J Olsson; Terence Dwyer; Katherine Smith; Richard Saffery
Journal:  Am J Epidemiol       Date:  2009-01-12       Impact factor: 4.897

Review 4.  Environmental epigenetics and its implication on disease risk and health outcomes.

Authors:  Shuk-Mei Ho; Abby Johnson; Pheruza Tarapore; Vinothini Janakiram; Xiang Zhang; Yuet-Kin Leung
Journal:  ILAR J       Date:  2012

Review 5.  Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation.

Authors:  Zdenko Herceg; Marie-Pierre Lambert; Karin van Veldhoven; Christiana Demetriou; Paolo Vineis; Martyn T Smith; Kurt Straif; Christopher P Wild
Journal:  Carcinogenesis       Date:  2013-06-07       Impact factor: 4.944

Review 6.  Second-hand smoke and human lung cancer.

Authors:  Ahmad Besaratinia; Gerd P Pfeifer
Journal:  Lancet Oncol       Date:  2008-07       Impact factor: 41.316

7.  The implications of DNA methylation for toxicology: toward toxicomethylomics, the toxicology of DNA methylation.

Authors:  Moshe Szyf
Journal:  Toxicol Sci       Date:  2011-02-04       Impact factor: 4.849

8.  Chemotherapeutic drug-induced ABCG2 promoter demethylation as a novel mechanism of acquired multidrug resistance.

Authors:  Eran E Bram; Michal Stark; Shachar Raz; Yehuda G Assaraf
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

9.  Benzo[a]pyrene diol epoxide suppresses retinoic acid receptor-beta2 expression by recruiting DNA (cytosine-5-)-methyltransferase 3A.

Authors:  Fei Ye; Xiao-Chun Xu
Journal:  Mol Cancer       Date:  2010-04-28       Impact factor: 27.401

10.  Exon expression in lymphoblastoid cell lines from subjects with schizophrenia before and after glucose deprivation.

Authors:  Maureen V Martin; Brandi Rollins; P Adolfo Sequeira; Andrea Mesén; William Byerley; Richard Stein; Emily A Moon; Huda Akil; Edward G Jones; Stanley J Watson; Jack Barchas; Lynn E DeLisi; Richard M Myers; Alan Schatzberg; William E Bunney; Marquis P Vawter
Journal:  BMC Med Genomics       Date:  2009-09-22       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.